Description
Angiotensin peptides exhibit pressor (vasoconstrictive) activity through binding of the angiotensin II type 1 (AT1) receptor, increasing blood pressure and volume.
Product Unit Size | Cost | Quantity | Stock |
---|
Angiotensin peptides exhibit pressor (vasoconstrictive) activity through binding of the angiotensin II type 1 (AT1) receptor, increasing blood pressure and volume.
Purity | ≥95% |
---|---|
Formula | C49H69N13O12 |
Formula Wt. | 1032.18 |
Solubility | Soluble in water. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Moon JY. Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension. Electrolyte Blood Press. 2013 Dec;11(2):41-45. PMID: 24627703.
Herichova I, Szantoova K. Renin-angiotensin system: upgrade of recent knowledge and perspectives. Endocr Regul. 2013 Jan;47(1):39-52. PMID: 23363256.
Dupont AG, Brouwers S. Brain angiotensin peptides regulate sympathetic tone and blood pressure. J Hypertens. 2010 Aug;28(8):1599-610. PMID: 20502352.
Phenyl hydrazide; neuronal oxidative stress inh...
Endogenous peptide hormone, involved in enteric...
ITC found in Nasturtium officinale (watercress)...
Tetracycline; protein translation inhibitor, MM...
Mycotoxin produced by Aspergillus; actin polyme...
Benzazepine derivative; D1 partial agonist, pot...
GHS-R1a agonist, γ-secretase inhibitor.
5-HT3 antagonist.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Protease inhibitor.
CDK2/4/6 inhibitor
Arylbenzimidazole; CHK2 inhibitor.
p110α PI3K inhibitor.
Precursor in the synthesis of hydroquinone, ant...
PI3K and mTOR inhibitor.
Cysteine-ITC conjugate.
NSAID; COX-2 inhibitor.
Inhibitor of FAK and ALK.
JAK3 and EGFR inhibitor.
Cathepsin inhibitor.